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Letters to the Editor
Iam writing in response to “Pharmacologic Treatment of Opioid Addiction During 
Pregnancy” by Keough and Fantasia (2017). Th e 
article nicely compares and summarizes the use 
of methadone and buprenorphine to treat sub-
stance use in pregnant women. I was dismayed, 
however, by the sections regarding neonatal con-
siderations and breastfeeding, which contained 
some problematic assertions and some inaccu-
rate conclusions. 
Th e use of the term addicted to refer to an 
infant of a woman who is using opioids is inap-
propriate. Th e literature clearly diﬀ erentiates 
between addiction and dependence; infants 
are incapable of the psychological activities 
that defi ne the compulsive nature of addiction. 
Infants are accurately described in the litera-
ture as being born dependent on the substance 
they have been exposed to. More concerning, 
however, is the statement that because of the 
immaturity of all systems, premature infants 
have more severe withdrawal symptoms. In fact, 
the exact opposite is true. Although the exact 
mechanisms for this muted response are not yet 
delineated in the literature, the Kocherlakota 
article (2014) cited by the authors is clear in this 
fact. 
Lastly, the paragraph that discusses breast-
feeding may be misleading and is not well refer-
enced. Although it is true that breastfeeding is 
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the standard of care, the amount of methadone 
excreted in breast milk is consistently found to 
be small and unlikely to cause withdrawal at 
cessation. The evidence regarding buprenor-
phine and breastfeeding is limited; however, 
it also appears that only small quantities of 
buprenorphine are expressed into breast milk. 
Guidelines from the Academy of Breastfeeding 
Medicine (Reece-Stremtan, Marinelli, & Acad-
emy of Breastfeeding Medicine, 2015) clarify 
the literature on these substances and support 
breastfeeding as something that will amelio-
rate symptoms of neonatal abstinence syndrome 
and may shorten duration of medical treatment 
required of a neonate. However, the most recent 
literature does not explain the exact mechanism 
and points to the act of breastfeeding rather 
than the breast milk itself as a potential support-
ive agent. The rate and duration of breastfeed-
ing for substance-exposed mothers are lower 
than for mothers who are not substance exposed 
(Wachman, Byun, & Phillip, 2010; Welle-Strand 
et al., 2013), making exclusive breastfeeding 
until introduction of solid food unlikely. There 
is a strong need for more research in this area. 
I appreciate the authors sharing important 
information on this most challenging of topics, 
and I hope that these comments may serve to 
clarify and update the information presented on 
the neonatal side of the maternal–infant dyad. 
Michele Savin, MSN, NNP-BC
Philadelphia, PA
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Authors’ Response
Thanks to Ms. Savin for her thoughtful review 
of our article. We appreciate the complicated 
medical and social implications opioid addic-
tion brings to women, particularly those of 
childbearing age, and to their families. Even 
more important is the expertise neonatal nurse 
practitioners can provide to their patients who 
are vulnerable and unable to care for them-
selves, as is the case with infants. 
The purpose of this article was to present an 
overview of what is currently known about the 
pharmacologic treatment of opioid addiction 
during pregnancy. We applaud Ms. Savin’s care-
ful attention to the neonatal component of the 
maternal–infant dyad. Adding to the complexi-
ties of treatment for both women and infants is 
the often observational and retrospective nature 
of the research in this area, which carries inher-
ent limits in the development of evidence-based 
interventions and applicability to clinical prac-
tice. The complicated social factors and resulting 
confounding variables within this population, 
coupled with significant ethical implications, 
add to the variability noted in the literature 
and contribute to the challenges of conducting 
research in this area.
We are grateful to Ms. Savin for her clinical 
expertise, perspectives on this important topic, 
and commitment to the health of women and 
their infants.
Lori Keough, PhD, MEd, FNP-BC, 
PMHNP-BC
Lowell, MA
Heidi Collins Fantasia, PhD, RN, 
WHNP-BC
Winthrop, MA
